<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-07-23T14:56:13Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/106852" metadataPrefix="oai_dc">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/106852</identifier><datestamp>2024-07-18T23:54:04Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Clathrin switches transforming growth factor-β role to pro-tumorigenic in liver cancer</dc:title>
   <dc:creator>Caballero-Díaz, Daniel</dc:creator>
   <dc:creator>Bertran, Esther</dc:creator>
   <dc:creator>Peñuelas-Haro, Irene</dc:creator>
   <dc:creator>Moreno-Càceres, Joaquim</dc:creator>
   <dc:creator>Malfettone, Andrea</dc:creator>
   <dc:creator>López-Luque, Judit</dc:creator>
   <dc:creator>Addante, Annalisa</dc:creator>
   <dc:creator>Herrera González, Blanca María</dc:creator>
   <dc:creator>Sánchez Muñoz, Aranzazu</dc:creator>
   <dc:creator>Alay, Ania</dc:creator>
   <dc:creator>Solé, Xavier</dc:creator>
   <dc:creator>Serrano, Teresa</dc:creator>
   <dc:creator>Ramos, Emilio</dc:creator>
   <dc:creator>Fabregat Romero, María Isabel</dc:creator>
   <dc:subject>577.1</dc:subject>
   <dc:subject>577.2</dc:subject>
   <dc:subject>Clathrin</dc:subject>
   <dc:subject>HCC</dc:subject>
   <dc:subject>TGF-b</dc:subject>
   <dc:subject>EGFR</dc:subject>
   <dc:subject>Liver</dc:subject>
   <dc:subject>Hepatocyte</dc:subject>
   <dc:subject>Intracellular traffic</dc:subject>
   <dc:subject>Cancer biology</dc:subject>
   <dc:subject>Anti-TGF-beta therapy</dc:subject>
   <dc:subject>Bioquímica (Farmacia)</dc:subject>
   <dc:subject>Biología molecular (Farmacia)</dc:subject>
   <dc:subject>24 Ciencias de la Vida</dc:subject>
   <dc:description>Background &amp; Aims: Upon ligand binding, tyrosine kinase receptors, such as epidermal growth factor receptor (EGFR), are recruited into clathrin-coated pits for internalization by endocytosis, which is relevant for signalling and/or receptor degradation. In liver cells, transforming growth factor-b (TGFb) induces both pro- and anti-apoptotic signals; the latter are mediated by the EGFR pathway. Since EGFR mainly traffics via clathrin-coated vesicles, we aimed to analyse the potential role of clathrin in TGF-b-induced signalling in liver cells and its relevance in liver cancer. Methods: Real-Time PCR and immunohistochemistry were used to analyse clathrin heavy-chain expression in human (CLTC) and mice (Cltc) liver tumours. Transient knockdown (siRNA) or overexpression of CLTC were used to analyse its role on TGF-b and EGFR signalling in vitro. Bioinformatic analysis was used to determine the effect of CLTC and TGFB1 expression on prognosis and overall survival in patients with hepatocellular carcinoma (HCC). Results: Clathrin expression increased during liver tumorigenesis in humans and mice. CLTC knockdown cells responded to TGF-b phosphorylating SMADs (canonical signalling) but showed impairment in the anti-apoptotic signals (EGFR transactivation). Experiments of loss or gain of function in HCC cells reveal an essential role for clathrin in inhibiting TGF-b-induced apoptosis and upregulation of its pro-apoptotic target NOX4. Autocrine TGF-b signalling in invasive HCC cells upregulates CLTC expression, switching its role to pro-tumorigenic. A positive correlation between TGFB1 and CLTC was found in HCC cells and patients. Patients expressing high levels of TGFB1 and CLTC had a worse prognosis and lower overall survival.
Conclusions: This work describes a novel role for clathrin in liver tumorigenesis, favouring non-canonical pro-tumorigenic TGF-b pathways. CLTC expression in human HCC samples could help select patients that would benefit from TGF-b-targeted therapy. Lay summary: Clathrin heavy-chain expression increases during liver tumorigenesis in humans (CLTC) and mice (Cltc), altering the cellular response to TGF-b in favour of anti-apoptotic/
pro-tumorigenic signals. A positive correlation between TGFB1 and CLTC was found in HCC cells and patients. Patients expressing high levels of TGFB1 and CLTC had a worse prognosis and lower overall survival. CLTC expression in HCC human samples could help select patients that would benefit from therapies targeting TGF-b.</dc:description>
   <dc:description>Ministerio de Ciencia, Innovación y Universidades (España)</dc:description>
   <dc:description>Instituto de Salud Carlos III</dc:description>
   <dc:description>European Commission-ERC</dc:description>
   <dc:description>Depto. de Bioquímica y Biología Molecular</dc:description>
   <dc:description>Fac. de Farmacia</dc:description>
   <dc:description>TRUE</dc:description>
   <dc:description>pub</dc:description>
   <dc:date>2024-07-18T10:20:18Z</dc:date>
   <dc:date>2024-07-18T10:20:18Z</dc:date>
   <dc:date>2020-01</dc:date>
   <dc:type>journal article</dc:type>
   <dc:type>AM</dc:type>
   <dc:identifier>https://hdl.handle.net/20.500.14352/106852</dc:identifier>
   <dc:identifier>0168-8278</dc:identifier>
   <dc:identifier>10.1016/j.jhep.2019.09.012</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>info:eu-repo/grantAgreement/MINECO//SAF2015-64149-R/ES/NUEVOS CONOCIMIENTOS SOBRE EL PAPEL DE LA NADPH OXIDASA NOX4 EN HEPATOCARCINOGENESIS. RELEVANCIA EN LA VIAS DE SEÑALIZACION DEL TGF-BETA Y DEL RECEPTOR DEL EGF/</dc:relation>
   <dc:relation>info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-094079-B-I00/ES/NUEVAS APROXIMACIONES EXPERIMENTALES PARA ANALIZAR EL PAPEL DE LA NADPH OXIDASA NOX4 EN REGENERACION Y CANCER HEPATICOS. RELACION CON LA VIA DEL TGF-BETA/</dc:relation>
   <dc:relation>info:eu-repo/grantAgreement/MINECO//SAF2015-69145-R/ES/NUEVAS PERSPECTIVAS SOBRE LOS MECANISMOS MOLECULARES QUE REGULAN LA EXPANSION Y EL DESTINO DE LAS CELULAS PROGENITORAS HEPATICAS DURANTE LA ENFERMEDAD CRONICA HEPATICA/</dc:relation>
   <dc:relation>info:eu-repo/grantAgreement/MINECO//BES-2013-064609/ES/BES-2013-064609/</dc:relation>
   <dc:relation>info:eu-repo/grantAgreement/MINECO//BES-2016-0077564/ES/BES-2016-0077564/</dc:relation>
   <dc:relation>info:eu-repo/grantAgreement/EC/FP7/201119/EU</dc:relation>
   <dc:relation>PITN-GA-2012-316549</dc:relation>
   <dc:relation>Caballero-Díaz, Daniel, et al. «Clathrin Switches Transforming Growth Factor-β Role to pro-Tumorigenic in Liver Cancer». Journal of Hepatology, vol. 72, n.o 1, enero de 2020, pp. 125-34. DOI.org (Crossref), https://doi.org/10.1016/j.jhep.2019.09.012.</dc:relation>
   <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
   <dc:rights>metadata only access</dc:rights>
   <dc:format>application/pdf</dc:format>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>